Honey bee as apitoxin, carries several active components, the most abundant of which is melittin, and the most biologically active are enzymes, particularly phospholipase A2. Bee venom is under laboratory and clinical research for its potential properties and uses in reducing risks for adverse events from bee venom therapy, rheumatoid arthritis, and use as an immunotherapy for protection against allergies from insect stings. Bee venom products are marketed in many countries, but, as of 2018, there are no approved clinical uses for these products which carry various warnings for potential allergic reactions. With an increased number of honey bees in a specific
VeNom Coding Group and we will make the necessary adjustments if required. We are currently working on other lists (procedures etc.) and these will be added to the VENOM codes in due course. The VENOM codes are a long list of conditions (Term name) identified by their unique numeric codes (Data Dictionary Id). There is a label field to identify the type of term (Container and Container ID–e.g. diagnosis, presenting complaint, administrative task etc.). The Top level modelling field includes the parent grouping / body system for each term. There is also a CRIS Active flag which is elected if the PMS prefers